162 related articles for article (PubMed ID: 3955197)
1. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
Montgomery PR; Sitar DS
Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
[TBL] [Abstract][Full Text] [Related]
2. Quantitative determination of five metabolites of aspirin by UHPLC-MS/MS coupled with enzymatic reaction and its application to evaluate the effects of aspirin dosage on the metabolic profile.
Li JP; Guo JM; Shang EX; Zhu ZH; Liu Y; Zhao BC; Zhao J; Tang ZS; Duan JA
J Pharm Biomed Anal; 2017 May; 138():109-117. PubMed ID: 28192718
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two enteric-coated acetylsalicylic acid preparations by monitoring steady-state levels of salicylic acid and its metabolites in plasma and urine.
Edgar B; Bogentoft C; Lagerström PO
Biopharm Drug Dispos; 1984; 5(3):251-60. PubMed ID: 6541512
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
[TBL] [Abstract][Full Text] [Related]
5. The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites.
Ho PC; Triggs EJ; Bourne DW; Heazlewood VJ
Br J Clin Pharmacol; 1985 May; 19(5):675-84. PubMed ID: 4005105
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.
Brantmark B; Wåhlin-Boll E; Melander A
Eur J Clin Pharmacol; 1982; 22(4):309-14. PubMed ID: 7106166
[TBL] [Abstract][Full Text] [Related]
7. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration.
Bogentoft C; Alpsten M; Ekenved G
J Pharm Pharmacol; 1984 May; 36(5):350-1. PubMed ID: 6145780
[TBL] [Abstract][Full Text] [Related]
8. A highly sensitive HPLC method for the simultaneous determination of acetylsalicylic, salicylic and salicyluric acids in biologic fluids: pharmacokinetic, metabolic and monitoring implications.
Krivosíková Z; Spustová V; Dzúrik R
Methods Find Exp Clin Pharmacol; 1996 Oct; 18(8):527-32. PubMed ID: 9044241
[TBL] [Abstract][Full Text] [Related]
9. Improved liquid-chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine.
Buskin JN; Upton RA; Williams RL
Clin Chem; 1982 May; 28(5):1200-3. PubMed ID: 7074905
[TBL] [Abstract][Full Text] [Related]
10. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.
Bogentoft C; Carlsson I; Ekenved G; Magnusson A
Eur J Clin Pharmacol; 1978 Dec; 14(5):351-5. PubMed ID: 32046
[TBL] [Abstract][Full Text] [Related]
11. Improved method for the determination of aspirin and its metabolites in biological fluids by high-performance liquid chromatography: applications to human and animal studies.
Mays DC; Sharp DE; Beach CA; Kershaw RA; Bianchine JR; Gerber N
J Chromatogr; 1984 Nov; 311(2):301-9. PubMed ID: 6520177
[TBL] [Abstract][Full Text] [Related]
12. Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.
Ali M; McDonald JW; Thiessen JJ; Coates PE
Stroke; 1980; 11(1):9-13. PubMed ID: 7355437
[TBL] [Abstract][Full Text] [Related]
13. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
Lui CY; Oberle R; Fleisher D; Amidon GL
J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
[TBL] [Abstract][Full Text] [Related]
14. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.
Mojaverian P; Rocci ML; Conner DP; Abrams WB; Vlasses PH
Clin Pharmacol Ther; 1987 Jan; 41(1):11-7. PubMed ID: 3802700
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants.
Cong D; Qi W; Liu X; Xu X; Dong L; Xue W; Li K
Drug Des Devel Ther; 2023; 17():2421-2429. PubMed ID: 37614377
[TBL] [Abstract][Full Text] [Related]
16. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
Canada AT; Little AH; Creighton EL
Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
[No Abstract] [Full Text] [Related]
17. Semi-micro column high-performance liquid chromatography with UV detection for quantification of aspirin and salicylic acid and its application to patients' sera administered with low-dose enteric-coated aspirin.
Ohwaki Y; Yamane T; Ishimatsu T; Wada M; Nakashima K
Biomed Chromatogr; 2007 Mar; 21(3):221-4. PubMed ID: 17221906
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet.
Lücker PW; Wetzelsberger N; Schettler T; Rogalla K
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):805-11. PubMed ID: 1297896
[TBL] [Abstract][Full Text] [Related]
19. Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography.
Liu JH; Smith PC
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):61-70. PubMed ID: 8634769
[TBL] [Abstract][Full Text] [Related]
20. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
Portek I; Graham G; Fleming A
Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
